Bath & Body Works Q4 sales fall 4.3% to $2.8 billion; 2025 EPS guided to $3.25-$3.60
Bath & Body Works reported fourth-quarter 2024 net sales of $2,788 million, down 4.3%, and diluted EPS of $2.09 versus $2.55 a year earlier. It also reported full-year 2024 net sales of $7,307 million, down 1.6%, and diluted EPS of $3.61 versus $3.84, and gave 2025 guidance of 1% to 3% net sales growth and EPS of $3.25 to $3.60, plus a new $500 million share repurchase authorization.
Key points
- Q4 2024 net sales were $2,788 million, down 4.3%; the company cited a headwind of about 500 basis points from the shifted fiscal calendar.
- Q4 2024 diluted EPS was $2.09, versus $2.55 in Q4 2023, which included a $112 million tax benefit; adjusted Q4 2023 EPS was $2.06.
- 2025 guidance calls for net sales growth of 1% to 3% and diluted EPS of $3.25 to $3.60, compared with reported 2024 EPS of $3.61.
- The board authorized a new $500 million share repurchase program, replacing about $120 million of remaining authority.
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.